Plné znění - 80/2017 Sb. m. s.

Sdělení o přijetí nového znění Přílohy I (Seznam zakázaných látek a metod dopingu pro rok 2017 - Mezinárodní standard) Mezinárodní úmluvy proti dopingu ve sportu

80/2017 Sb. m. s.

Sdělení

INFORMACE

80

XXXXXXX

Xxxxxxxxxxxx zahraničních xxxx,

xxxxxx xx xxxx x xxxxxxxx xxxxxxx Xxxxxxxxxxxx xxxxxxxxxxxx věcí č. 58/2007 Xx. m. x. x č. 46/2008 Sb. x. x.

 

Xxxxxxxxxxxx zahraničních xxxx xxxxxxx, xx dne 28. xxxxxxxxx 2016 xxxx xxxxxxxxx xxxxxxxxxx XXXXXX oznámeno xxxxxxxxx xxxxxx znění Přílohy X (Xxxxxx zakázaných xxxxx x xxxxx xxxxxxx xxx rok 2017 - Xxxxxxxxxxx xxxxxxxx) Mezinárodní xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾.

X xxxxx xxxxxx Xxxxxxx X xxxxxxxx xxxxxxx Xxxxxxxxx Xxxxx xxxxxxxxx x prezident xxxxxxxxx podepsal xxxxxxx x xxxxxxx změn Xxxxxxx I Xxxxxx xxxxxxxxxx.

Xxxx xxxxx Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2017 x xxx Českou xxxxxxxxx vstoupilo x xxxxxxxx xxx 30. xxxxx 2017.

Xxxx vstupu xxxxxx xxxxx Přílohy X v xxxxxxxx xxxxxxxx xxxxxx xxxxx Xxxxxxx X xxxxxx xx 1. xxxxx 2016, xxxxxxxxx pod č. 26/2017 Sb. m. s.

Xxxxxxxx znění Xxxxxxx X x xxxx xxxxxxx xx českého xxxxxx se xxxxxxxxx xxxxxxxx.

XXXXXXX ANTIDOPINGOVÝ KODEX

SEZNAM XXXXXXXXXX LÁTEK X XXXXX DOPINGU PRO XXX 2017

XXXXXXXXXXX XXXXXXXX

Xxxxxxxxx xxxx Xxxxxxx bude xxxxxxxxx XXXX a xxxx xxxxxxxxxx v xxxxxxxxxx x xxxxxxxxxxxxx.

X xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxx anglickou x xxxxxxxxxxxx xxxxx xxxx xxxxxxxxxxx anglická verze.

Tento Xxxxxx bude xxxxxx xx 1. ledna 2017 

XXXXXX XXXXXXXXXX XXXXX X XXXXX XXXXXXX XXX XXX 2017

SVĚTOVÝ XXXXXXXXXXXXX XXXXX

Xxxxxx od 1. xxxxx 2017

Podle xxxxxx 4.2.2 Světového xxxxxxxxxxxxxxx kodexu xxxxxxx Xxxxxxxx látky xxxxx xxxxxxxxxx xx "Xxxxxxxxxx xxxxx" xxxxx látek xx xxxxxx S1, X2, X4.4, X4.5 x S6(a) a Xxxxxxxxxx xxxxx M1, X2 x X3.

XXXXX X METODY XXXXXXXX XXXXX (XXX XXXXXXX X XXXX XXXXXX)

XXXXXXXX XXXXX

X0. XXXXXXXXXXX LÁTKY

Jakákoliv xxxxxxxxxxxxxx xxxxxx xxxxx, která xxxx xxxxxxxx v xxxxxxxxxxxxx xxxxxxx Seznamu x není aktuálně xxxxxxxxx xxx xxxxxxx xxxxxxxxxxxx xxxxxxx jakýmkoliv xxxxxxx zdravotnickým xxxxxxxxxx xxxxxx (xxxx. xxxxxx x xxxxxxxxxxxx xxxx xxxxxxxxx stadiu xxxxxxx xxxx xx xxxxxxxx xxxxxxxxxx, syntetické xxxxx, xxxxx schválené xxxxx xxx xxxxxxxxxxx xxxxxxx), xx zakázána stále.

S1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

(x) Xxxxxxxx* XXX, zahrnující:

1-androstendiol (5α-xxxxxxx-1-xx-3ß,17ß-xxxx);

1-xxxxxxxxxxxxx (5α-androst-1-en-3,17-dion);

bolandiol (estr-4-en-3ß, 17ß-xxxx);

xxxxxxxxxx;

xxxxxxx ([1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17α-ol);

dehydrochlormethyltestosteron (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx);

xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17ß-xx);

xxxxxxxxxxx;

xxxxxxxxxxxxx (19-xxxxxxxxx-4-xx-17α-xx);

xxxxxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxx (17α-xxxxxx[1,2,5]xxxxxxxxxx[3',4':2,3]-5α-xxxxxxxxx-17ß-xx);

xxxxxxxxx;

4-xxxxxxxxxxxxxxxxxx (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx);

xxxxxxxxxx;

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx (17ß-hydroxy-17α-methylandrosta-1,4-dien-3-on);

metenolon;

methandriol;

metasteron (17ß-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx);

xxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx);

xxxxxx-1-xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxx-5α-xxxxxxx-1-xx-3-xx);

xxxxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xx);

xxxxxXxxxxxxxxxxx;

xxxxxxxxxx (xxxxxxxxxxxxxxx (17ß-hydroxy-17α-methylestra-4,9,11-trien-3-on);

miboleron;

norboleton;

norethandrolon;

norklostebol;

oxabolon;

oxandrolon;

oxymesteron;

oxymetolon;

prostanozol (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx);

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxx;

1-xxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxx-1-xx-3-xx);

xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx);

xxxxxxxxx (17ß-xxxxxxxxxxx-4,9,11-xxxxx-3-xx);

x xxxxx xxxxx s xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Endogenní** XXX, xxxxx xxxx podány xxxxxxxx:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3ß,17ß-xxxx);

xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx);

xxxxxxxx;

xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx);

xxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxxxx-3xx); 

xxxxxxxxx (19-xxxxxxxxxxxxxx);

19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);

19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);

xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx);

xxxxxxxxxxx;

x xxxxxx xxxxxxxxxx a xxxxxxx, xxx xx x xxxxxxxx xxxxx na xx:

5α-xxxxxxxxx-3α,17α-xxxx;

5α-xxxxxxxxx-3α,17ß-xxxx;

5α-xxxxxxxxx-3ß,17α-xxxx;

5α-xxxxxxxxx-3ß,17ß-xxxx;

5ß-xxxxxxxxx-3α,17ß-xxxx;

5α-xxxxxxx-2-xx-17-xx;

xxxxxxx-4-xx-3α,17α-xxxx;

xxxxxxx-4-xx-3α,17ß-xxxx;

xxxxxxx-4-xx-3ß,17α-xxxx;

xxxxxxx-5-xx-3α,17α-xxxx;

xxxxxxx-5-xx-3α,17ß-xxxx;

xxxxxxx-5-xx-3ß,17α-xxxx;

4-xxxxxxxxxxxxx (androst-4-en-3ß,17ß-diol);

5-androstendion (xxxxxxx-5-xx-3,17-xxxx);

xxxxxxxxxxx;

xxx-xxxxxxxxxxxxxxxxxx;

xxxxxxxxxxxxxx;

xxxxxxxxxxxxxx;

3ß-xxxxxxx-5α-xxxxxxxxx-17-xx;

7α-xxxxxxx-XXXX;

7ß-xxxxxxx-XXXX;

7-xxxx-XXXX;

19-xxxxxxxxxxxxxx;

19-xxxxxxxxxxxxxxxxx.

2. Xxxxxxx xxxxxxxxxx látky, xxxxxxxxxx:

Xxxxxxxxxxx; xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM, xxxx. xxxxxxx a xxxxxxx); tibolon; zeranol x zilpaterol, xxx xx x xxxxxxxx xxxxx xx xx.

Xxx xxxxx xxxxxxx této xxxxx: * "xxxxxxxx" se xxxxxxxx x látce, xxxxxx tělo normálně xxxxxxxxx xxxxxxxxxxx. ** "xxxxxxxxx " xx xxxxxxxx x xxxxx, xxxxxx xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx.

X2. XXXXXXXXX XXXXXXX, XXXXXXX XXXXXXX, PŘÍBUZNÉ XXXXX A MIMETIKA

Následující xxxxx x xxxxx xxxxx s xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx biologickými účinky xxxx xxxxxxxx:

1. Agonisté xxxxxxxxxxxxxxxxx receptoru:

1.1 Xxxxx xxxxxxxxxxx xxxxxxxxxxx (XXX) xxxxxx xxxx.

xxxxxxxxxxxx (dEPO);

erytropoetinů (XXX);

XXX-Xx;

XXX-xxxxxxxxxxx xxxxxxx (EMP), xxxx. CNTO 530 x xxxxxxxxxxx;

xxxxxxxxxx XXXX, xxxx. K-11706;

methoxypolyethylenglykol-epoetin beta (XXXX);

xxxxxxxxxx xxxxxxxxxxxxxxxx růstového xxxxxxx xxxx (XXX-xxxx), xxxx. xxxxxxxxxxx, luspatercept;

1.2 Xxxxxxxx xxxxxxxxxxxxxxxxxx XXX xxxxxxxxx, xxxx.

XXX-290;

xxxxxx EPO;

karbamylovaný XXX;

2. Stabilizátory hypoxii xxxxxxxxxxxxxx xxxxxxx (HIF), xxxx. xxxxxx, molidustat x roxadustat (XX-4592); x aktivátory XXX, xxxx. xxxxx x xxxxx.

3. Choriogonadotropin (XX) x xxxxxxxxxxxx hormon (XX) x jejich xxxxxxxxxx xxxxxxx, např. xxxxxxxxx, xxxxxxxxxxx a xxxxxxxxxxx, x xxxx.

4. Xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxx xxxxxxx, xxxx. xxxxxxxxxxxx.

5. Růstový xxxxxx (XX) x xxxx xxxxxxxxxx xxxxxxx včetně: xxxxxxx xxxxxxxxxxxx xxxxxxx xxxxxx (GHRH) a xxxx xxxxxxx, např. XXX-1295, xxxxxxxxxxx x xxxxxxxxxxxx; xxxxxxxxxxx xxxxxxxxx xxxxxxx (XXX), xxxx. xxxxxxxx x xxxxxxx xxxxxxxx, xxxx. anamorelinu x ipamorelinu; xxxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx (XXXX), např. xxxxxxxxxxxxx, XXXX-6, xxxxxxxxxx x xxxxxxxxxxxx (XXXX- 2).

Kromě xxxx xxxx xxxxxxxx xxxxxxxxxxx růstové faktory:

Fibroblastové xxxxxxx xxxxxxx (XXXx); xxxxxxxxxxxx xxxxxxx xxxxxx (XXX); xxxxxxxx xxxxxxx xxxxxxx faktor-1 (XXX-1) x xxxx analoga; xxxxxxxxxx růstové xxxxxxx (XXX); xxxxxxx xxxxxx xxxxxxxx x xxxxxxxx xxxxxxxx (PDGF); vaskulárně-endoteliární xxxxxxx xxxxxx (VEGF), xxxxxx xxxx jakékoliv xxxx xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxx nebo xxxxxxxxx xxxxxxxx xxxxx, xxxxx a vaziva, xxxxxx xxxxxxxx, využití xxxxxxx, regenerativní kapacitu xxxx xxxxxxxxxxx xxxx xxxxxxxxx vláken.

S3. XXXX2- XXXXXXXX

Xxxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxx2- xxxxxxxx, xxxxxx xxxxx xxxxxxxxx xxxxxxx, xxxx xxxxxxxx.

Xxxxxxxx (xxx xx x xxxxxxxx xxxxx xx xx):

Xxxxxxxxx; xxxxxxxxxx; higenamin; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; salbutamol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx.

Xxxxxxxx xxxx:

• xxxxxxxxx xxxxxxxxxx: xxxxxxxxx 1600 xxxxxxxxxx xx 24 xxxxx, nepřekročit 800 xxxxxxxxxx za xxxxxxx 12 xxxxx;
• xxxxxxxxx xxxxxxxxxx: xxxxxxxxx dodaná xxxxx 54 xxxxxxxxxx xx 24 xxxxx;
• xxxxxxxxx xxxxxxxxxx: xxxxxxxxx 200 xxxxxxxxxx xx 24 xxxxx.

Xxxxxxxxxx xxxxxxxxxxx x moči x xxxxxxxxxxx xxxxx xxx 1000 xx/xx x xxxxxxxxxx xxxxxxxxxxx x xxxx x xxxxxxxxxxx xxxxx xxx 40 xx/xx nebude xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx použití, xxx xxxx považována za xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxx, xx abnormální výsledek xxx způsoben xxxxxxxx xxxxxxxxxxxx xxxxx (v xxxxxxxx) xxxxx, xxx xxxx uvedená maximální xxxxx.

X4. XXXXXXXXX A XXXXXXXXXXX MODULÁTORY

Zakázané jsou xxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx:

1. Inhibitory xxxxxxxx, zahrnující:

Aminoglutethimid;

anastrozol;

androsta-1,4,6-trien-3-17-dion (xxxxxxxxxxxxxxxxx);

xxxxxxxx-3,5-xxxx-7-17-xxxx (xxxxxxxxx);

4-xxxxxxxxx-3,6,17-xxxxx (6-xxx);

xxxxxxxxx;

xxxxxxxxx;

xxxxxxxx;

xxxxxxxxxxx,

xxx xx x xxxxxxxx xxxxx xx xx.

2. Selektivní xxxxxxxxxx estrogenových receptorů (XXXX), xxxxxxxxxx:

Xxxxxxxxx;

tamoxifen;

toremifen, xxx ne x xxxxxxxx xxxxx xx xx.

3. Xxxxxxx xxxxxxxxxxxxxx xxxxx zahrnující:

Cyklofenil; xxxxxxxxxxx x xxxxxxxx, xxx xx s xxxxxxxx xxxxx xx ně.

4. Xxxxx xxxxxxxxxxxx xxxxxx(x) xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, xxx xx

x xxxxxxxx xxxxx xx xx.

5. Metaboiické modulátory:

5.1 Xxxxxxxxxx XXX-xxxxxxxxxx proteinkinázy (XXXX), xxxx. XXXXX; x Xxxxxxxx Xxxxxxxxx xxxxx aktivovaného xxxxxxxxxxxxxx xxxxxxxxxxxxx (XXXXδ), xxxx. XX 1516;

5.2 Xxxxxxxx x xxxxxxxx xxxxxxxx;

5.3 Xxxxxxxxx;

5.4 Trimetazidin.

S5. XXXXXXXXX X MASKOVACÍ XXXXX

Xxxxxxxxxxx xxxxxxxxx x maskovací xxxxx xxxx xxxxxxxx, xxxxxx jako xxxxx xxxxx s xxxxxxxx xxxxxxxxx xxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx účinky.

Zahrnují:

• Desmopressin, xxxxxxxxxxxxxxx (xxxx. glycerol, xxxxxxxxxx xxxxxx xxxxxxxx, xxxxxxxx, xxxxxxxxxxxxxxxxxx x xxxxxxxxx), probenecid, xxx xx x xxxxxxxx xxxxx na ně.

• Acetazolamid, xxxxxxxx, bumetanid, furosemid, xxxxxxxxxxxx, xxxxxxxxx, kanrenon, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, hydrochlorothiazid, chlorothiazid), xxxxxxxxxx a xxxxxxx (xxxx. tolvaptan), ale xx s xxxxxxxx xxxxx na ně.

S xxxxxxxx:

• xxxxxxxxxxxx, xxxxxxxxx a xxxxxx podání inhibitorů xxxxxxxxxxxxxx (xxxx. xxxxxxxxxxx x xxxxxxxxxxxx)

• Xxxxxxxxx podání xxxxxxxxxxxx pro xxxxx xxxxxxxxx

Xxxxx xxxxxxxxxxx xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxxxx limitem (xx. xxxxxxxxxx, salbutamol, xxxxx, xxxxxxx, metylefedrin a xxxxxxxxxxxxx) xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxx

xxxxxxxx Xxx Xxxxxxx ve xxxxxxx x diuretikem xxxx jinou maskovací xxxxxx, xxxx považováno xx Xxxxxxxxx laboratorní xxxxx, xxxxx Sportovec xxxx schválenou Xxxxxxxxxxxxx xxxxxxx (TV) xx xxxx látku xxxxx x té, xxxxx xxx xxxx udělena xx xxxxxxxxxx xxxx xxxxx xxxxxxxxx xxxxx.

XXXXXXXX XXXXXX

X1. MANIPULACE X XXXX X XXXXXXXX XXXXXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

1. Xxxxxx nebo xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx, xxxxxxxx (xxxxxxxxx) xxxx xxxxxxxxxxx krve nebo xxxxxxxxx krvinek x xxx xxxxxxxxx produktů xxxxxxxxxxx xxxxxx xx xxxxxxxxx systému.

2. Umělé xxxxxxxxx spotřeby, xxxxxxx xxxx dodávky kyslíku.

Zahrnující:

modifikované xxxxxxxxxxxxx produkty (např. xxxxxx xxxxxxxx xxxxxxxx xx xxxxxxxxxxx x xxxxxxxxxxxxxxxxxx hemoglobiny), xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxx (XXX13), xxx ne s xxxxxxxx xxxxx xx xx. Xxxxxxxxx suplementace xxxxxxxx xxxxxxxx xxxx.

3. Xxxxxxxxx forma xxxxxxxxxxxxxxx xxxxxxxxxx s xxxx xxxx x xxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxx způsoby.

M2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

Xxxxxxxx xx následující:

1. Xxxxxxxxx, xxxx Xxxxx x Xxxxxx, za xxxxxx xxxxxxx xxxxxxxxx a xxxxxxxx Xxxxxx xxxxxxxxxx xxx Xxxxxxxxx xxxxxxxx. Xx zahrnuje xxxxxx x/xxxx xxxxxx (např. xxxxxxxxxx) xxxx, ale xx s xxxxxxxx xxxxx xx xx.

2. Xxxxxxxxxx infuze x/xxxx xxxxxxx xxxx xxx 50 xx za 6 xxxxx xxxxx xxxxxx legitimně xxxxxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx, xxxxxxxxxxxxx zákroků xxxx klinických xxxxxxxxxxxxx xxxxx.

X3. XXXXXX XXXXXX

X xxxxxx potenciálu ke xxxxxxx xxxxxxxxxxx xxxxxx xx zakázáno následující:

1. Xxxxxxxx polymerů xxxxxxxxxx xxxxxxx xxxx jejich xxxxxxx;

2. Xxxxxxx xxxxxxxxxx xxxx geneticky modifikovaných xxxxx;

XXXXX A METODY XXXXXXXX XXX XXXXXXX

Xxxxx xxxxxxxxx S0 až X5 x X1 xx X3 uvedených xxxx

xxxx Xxx Xxxxxxx xxxxxxxx i xxxxxxxxxxx xxxxxxx:

XXXXXXXX XXXXX

X6. STIMULANCIA

Všechna xxxxxxxxxxx xxxxxx xxxxx xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx, xxxx. x- x X-, xxxx xxxxxxxx.

Xxxxxxxxxxx xxxxxxxx:

(x) Xxxxxxxxxxxx xxxxxxxxxxx:

Xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxx /4-xxxxxxxxxxxxxx (karfedon)/,

furfenorex,

klobenzorex,

kokain,

kropropamid,

krotetamid,

lisdexamfetamin,

mefenorex,

mefentermin,

metamfetamin (x-),

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxxxx, 

x-xxxxxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx.

Xxxxxxxxxxxx, xxxxx není xxxxxxxx xxxxxxx v xxxxx odstavci, je Xxxxxxxxxxx látkou.

(b) Xxxxxxxxxx xxxxxxxxxxx.

Xxxxxxxx (xxx xx x omezením xxxxx xx ně):

Adrenalin (xxxxxxxxx)****,

xxxxxxxxxxx,

xxxxxxxxxxxxxxxxx,

xxxxxxx***,

xxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxx x xxxx deriváty,

fenkamfamin,

fenmetrazin,

fenprometamin,

heptaminol,

hydroxyamfetamin (xxxxxxxxxxxxxxxxxxxx),

xxxxxxxxxxxx,

xxxxx**,

xxxxxxx a xxxx xxxxxxx (např. xxxxxxxx, xxxxxxxxx x xxxx-xxxxxxxxxxxxxxxxxxxxx),

xxxxxxxxxxxxxxx,

xxxxxxxxxxxx,

xxxxxxxxxxxx***,

xxxxxxxxxxxxxxxxxxxxxxxx,

xxxxxxxxxxxx,

4-xxxxxxxxxx-2-xxxx (xxxxxxxxxxxxxx),

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxx (xxxxxxxxxxxxx),

xxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxxxx,

xxxxxxxxxxxxx*****,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx),

xxxxxxxxxxxxx

x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx biologickými xxxxxx.

X výjimkou:

• klonidinu

• derivátů xxxxxxxxx x xxxxxxx xxxxxx xxxxxxxx/xxxxxx xxxxxxx a xxxxxxxxxxx xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2017*.

* Bupropion, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, kofein, xxxxxxx, pipradrol x xxxxxxxx: Xxxx látky xxxx xxxxxxxx xx Xxxxxxxxxxxxxx programu 2017 x xxxxxx xxxxxxxxxx xx Xxxxxxxx xxxxx.

** Xxxxx: xx xxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 5 xxxxxxxxxx x 1 xx xxxx.

*** Efedrin x xxxxxxxxxxxxx: jsou xxxxxxxx xxx xxxxxxxxxxx xxxxx než 10 xxxxxxxxxx x 1 xx xxxx.

**** Xxxxxxxxx (xxxxxxxxx): není zakázán xxx xxxxxxxx xxxxxx, xxxx. nosní, oční xxxxxxxx xxxx jeho xxxxxx xxxxxxxx s xxxxxxxxx xxxxxxxxxx.

***** Xxxxxxxxxxxxx: xx zakázán, xxxxx xxxx xxxxxxxxxxx v xxxx je vyšší xxx 150 xxxxxxxxxx xx mililitr.

S7. XXXXXXXXX

Xxxxxxxx xx následující:

Buprenorfin,

dextromoramid,

diamorfin(heroin),

fentanyl a xxxx xxxxxxxx,

xxxxxxxxxxx,

xxxxxxx,

xxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxx.

X8. KANABINOIDY

Zakázané xx následující:

• Přírodní (např. xxxxx, konopí x xxxxxxxxx) xxxx syntetický xxxxx9-xxxxxxxxxxxxxxxxxxx (XXX).

• Xxxxxxxxxxxxxx, např. "Xxxxx", XXX018, XXX073 x XX-210.

X9. GLUKOKORTIKOIDY

Všechny xxxxxxxxxxxxxxx xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx.

XXXXX XXXXXXXX X&xxxx;XXXXXXXX XXXXXXXX

X1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx xxxxx Xxx Soutěži x xxxxxxxxxxxxx sportech. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx krve. Xxxxxxx xxxxxxx xxx porušení xxxxxxxxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxxx alkoholu x xxxx 0,10 x/x.

• Xxxxxxxxxxxx sport (XXX)

• Xxxxxxxxxxx (XX)

• Xxxxxxx xxxxxx x xxxxxxxxxxxx (FAI)

• Vodní xxxxxxxxxx (XXX)

X2. XXXX-XXXXXXXXX

Xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx v xxxxxxxxxxxxx xxxxxxxx Při Xxxxxxx, x xxx xx xx xxxxxxxx x Xxxx soutěž.

• Automobilový xxxxx (XXX)

• Xxxxxxxx (xxxxxxx xxxxxxxxxx) (XXXX)

• Xxxx (XXX)

• Xxxxxxxxxxx (XX)*

• Xxxxxxxx (FIS) - xxxxx xx xxxxxx x xxxxxxxxxxx lyžování-skoky x X-xxxxx, a xxxxxxxxx X-xxxxx x "xxx air"

• Podvodní sporty (xxxxxxxxx xxxxxxxx) (XXXX) x disciplínách xxxxxxxxxx xxxx x xxxxxxxxx xxxx xxx xxxxxxx, xxxxxxxxx xxxxx x xxxxxxxxx xxxx bez xxxxxxx, free xxxxxxxxx, xxxx xxxx, spearfishing, xxxxxxxx apnoe, xxxxxxx xxxxxxxx xx terč x xxxxxxxxxx xxxx.

• Xxxxxxx (XXXX, XXX)*

• Xxxxx (WDF)

* Xxxxxxxx také Xxxx xxxxxx

Xxxx-xxxxxxxxx zahrnují xxxxxxxxxxx xxxxx:

Xxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxx,

xxxxxxxxxx,

xxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxx,

xxxxxxxxxx, 

xxxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxxxx,

xxxxxxx,

xxxxxxx,

xxx xx s xxxxxxxx pouze xx xx.

Xxxxxxxxx

Xxxxxx xxxxxxx x. 80/2017 Xx. x. x. xxxxx xxxxxxxxx xxxx 4.1.2018.

Xxxxxx xxxxxxx x. 80/2017 Xx. x. x. xxx xxxxxx právním xxxxxxxxx č. 36/2019 Sb. m. s. s xxxxxxxxx xx 26.7.2019.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx není xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.

1) Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx, xxxxxxx dne 19. xxxxx 2005 x Xxxxxx, byla xxxxxxxxx x xxxxxxxxx xxxxx x s xxxxxxxxx do českého xxxxxx xxx č. 58/2007 Sb. m. s.

Xxxx xxxxx xxxxxxxx Xxxxxx xx českého xxxxxx xxxx xxxxxxxxx xxx č. 46/2008 Sb. m. s.